C.G. Moore is a registered patent attorney in the Firm's Mandeville office. Dr. Moore concentrates his practice on patent matters relating to biotechnology, chemistry, and pharmaceuticals, with particular focus on molecular and cellular biology, small molecule chemistry, neurobiology, drug delivery and medical devices.

In addition to the preparation and prosecution of patent applications, Dr. Moore’s experience includes managing patent portfolios, drafting license agreements, freedom-to-operate opinions and non-infringement opinions, performing due diligence in connection with public financings and acquisitions, supporting patent and trademark litigation, and participating in appeals and reexamination proceedings before the United States Patent and Trademark Office.

Dr. Moore gained significant research experience in the life sciences through his work as a research assistant at the Oregon Health Sciences University and later at the Massachusetts General Hospital. He also acquired first-hand experience with the biotechnology industry while working with the New England Organ Bank and the Transplant Resource Center of Maryland.

As a Ph.D. candidate at the Johns Hopkins University School of Medicine, Dr. Moore's thesis research focused on the regulation of glutamate receptors and their interaction with Homer proteins, demonstrating a role for coordinated phosphorylation and isomerization.

During law school, Dr. Moore was an intern and patent agent with the Tulane University Office of Technology Transfer and Business Development, where he prepared patent applications, participated in patent licensing transactions and developed marketing strategies.

Representative Technologies

• Biotechnology / Chemical / Pharmaceutical — Small molecule and protein pharmaceutical compounds; DNA regulatory elements; liposomes; antisense DNA vaccines; plasmid expression vectors
• Medical — Suture anchor assemblies; vascular stents; remote endarterectomy devices; stent placement and manipulation devices; medication therapy management and quality assurance methods

Pending Biotechnology, Chemical, & Pharmaceutical Patent Applications

• Thermoresponsive Microparticle Composite Hydrogels for Electrophoresis (U.S. Patent Pub. No. 2009/0127116)
• System for Pulling Out Regulatory Elements using Yeast (U.S. Patent Pub. No. 2008/0248467)
• System for Pulling Out Regulatory Elements In vitro (U.S. Patent Pub. No. 2008/0248958)
• Pharmacological Method for Treatment of Neuropathic Pain (U.S. Patent Pub. No. 2007/0249561)
• Bisbenzamidines and Bisbenzamidoximes for the Treatment of Human African Trypanosomiasis (U.S. Patent Pub. No. 2008/0139534)
• Antisense Respiratory Syncytial Virus Vaccine and Therapy (Patent application not yet published)
• Redox-Gated Liposomes (Patent application not yet published)
• Biologically Active Recombinant Human Saposin C and PSAP (Patent application not yet published)
• Photonic Crystal Architectures for Frequency- and Angle-Selective Thermal Emitters (Patent application not yet published)
• Inducible Fluorescently-Tagged Protein Expression System (Patent application not yet published)

Publications & Speaking Engagements

• Panelist – “Intellectual Property & Technology Transfer Career Panel,” Johns Hopkins University, Professional Development Office Seminar (Oct. 2008)
• Author - "Generic Biologic Drugs:  What's in a Name?" 5 The SciTech Lawyer 16 (Fall 2008)
• Author – "Federal Circuit: No § 271(e)(1) Safe Harbor For Patented Inventions Not Regulated By FDA," 6 Health Lawyers Weekly 3 (August 22, 2008)
• Author – "Killing the Bayh-Dole Act's Golden Goose," 8 Tul. J. Tech. & Intell. Prop. 151 (2006)
• Author – "Recent Developments in Intellectual Property Law," 52 LA. B.J. 294 (2004)

Professional Honors & Activities

• Member – American Bar Association, Member of Science & Technology Law and Intellectual Property Sections
• Member – Louisiana State Bar Association, Member of Intellectual Property Section
• Member – American Intellectual Property Law Association, Member of Biotechnology, Patent Law, and Emerging Technologies Committees
• Member – Licensing Executives Society, Member of Nanotechnology, and Diagnostics, Genomics & Research Tools Committees 

Admissions

• U.S. Patent and Trademark Office, No. 53,345
• U.S. Court of Appeals for the Federal Circuit
• U.S. Court of Appeals for the Fifth Circuit
• U.S. District Courts for the Eastern, Middle, and Northern Districts of Louisiana
• Louisiana, 2006

Education

• Tulane University, J.D., 2006
• Johns Hopkins University School of Medicine, Ph.D. (Neuroscience), 2004
  • Thesis: Regulation of Group I Metabotropic Glutamate Receptor Function and Homer Interaction by Phosphorylation of the Homer Ligand
• Portland State University, B.S. (Biology), 1995
• Reed College, B.A. (Chemistry), 1990
  • Thesis: Building a better backbonder: ligation of Mo⁰ by methylpyrazine using molybdenum hexacarbonyl and methylpyrazinium triflate